Skip to content

Anesthetic effect of nalbuphine combined with remazolam in daytime hysteroscopic surgery

Anesthetic effect of nalbuphine combined with remazolam in daytime hysteroscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065518
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopic surgery

Interventions

the propofol group:Intravenous propofol
the remazolam group :Intravenous remazolam
the remazolam+propofol group:Start with propofol, then remazolam

Sponsors

Weifang Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age between 30 and 50 years old. 2. Body mass index (BMI) 18–30 kg/m2. 3. American Society of Anesthesiologists (ASA) class I–II. 4. Patients underwent painless hysteroscopy and therapeutic surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with respiratory or cardiac dysfunction. 2. Those suffering from severe hepatic or renal insufficiency, and neuropsychiatric diseases. 3. Patients with severe hypertension, and diabetes mellitus. 4. Patients who had a history of sedative and analgesic administration. 5. Those who were allergic or contraindicated to benzodiazepines, opioids, propofol, flumazenil, or naloxone. 6. Those who escalated to tracheal intubation and general anesthesia, a procedure time of more than 1 h, or an inability to communicate.

Design outcomes

Primary

MeasureTime frame
the total incidence of adverse events;

Secondary

MeasureTime frame
the changes of perioperative mean arterial pressure;the changes of perioperative heart rate;the changes of perioperative saturation of peripheral oxygen;perioperative MOAAS sedation score;Recovery room time;Out of room sedation score;analgesia score after leaving the room;the examination time;the anesthesia recovery time ;

Countries

China

Contacts

Public ContactJingjing zhang

Weifang Maternal and Child Health Hospital

18896730963@163.com+86 135 8367 9100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026